Wells Fargo & Company Cuts Billiontoone (NASDAQ:BLLN) Price Target to $90.00

Billiontoone (NASDAQ:BLLN) had its target price trimmed by Wells Fargo & Company from $110.00 to $90.00 in a research report released on Thursday morning,Benzinga reports. The firm currently has an equal weight rating on the stock.

Several other equities research analysts also recently issued reports on BLLN. Piper Sandler reiterated an “overweight” rating on shares of Billiontoone in a report on Wednesday, December 10th. William Blair assumed coverage on Billiontoone in a research report on Monday, December 1st. They issued an “outperform” rating for the company. Stifel Nicolaus started coverage on shares of Billiontoone in a research note on Monday, December 1st. They set a “buy” rating and a $145.00 price target on the stock. Jefferies Financial Group started coverage on shares of Billiontoone in a research report on Monday, December 1st. They set a “hold” rating and a $117.00 price target on the stock. Finally, Weiss Ratings assumed coverage on shares of Billiontoone in a report on Tuesday, February 3rd. They issued a “sell (d)” rating for the company. Six investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $129.57.

Billiontoone Price Performance

NASDAQ:BLLN opened at $73.51 on Thursday. Billiontoone has a fifty-two week low of $66.00 and a fifty-two week high of $138.70. The business’s 50 day moving average is $85.55. The stock has a market cap of $3.36 billion and a PE ratio of 735.10.

Billiontoone (NASDAQ:BLLN) last announced its earnings results on Wednesday, March 4th. The company reported $0.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.07. The firm had revenue of $96.05 million during the quarter, compared to analysts’ expectations of $85.85 million. Billiontoone’s revenue for the quarter was up 113.0% compared to the same quarter last year.

Hedge Funds Weigh In On Billiontoone

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Rossby Financial LCC acquired a new position in shares of Billiontoone during the fourth quarter worth about $25,000. Wells Fargo & Company MN acquired a new stake in Billiontoone in the fourth quarter valued at approximately $76,000. Smartleaf Asset Management LLC purchased a new position in Billiontoone in the fourth quarter worth approximately $80,000. Nano Cap New Millennium Growth Fund L P acquired a new position in Billiontoone during the 4th quarter worth approximately $82,000. Finally, Renaissance Capital LLC acquired a new position in Billiontoone during the 4th quarter worth approximately $201,000.

Key Headlines Impacting Billiontoone

Here are the key news stories impacting Billiontoone this week:

• Positive Sentiment: Q4 earnings beat and rapid revenue growth — BillionToOne reported $0.11 EPS vs. $0.04 consensus and revenue of $96.05M (vs. $85.85M est.), with revenue up ~113% year-over-year; results and commentary point to accelerating demand. View Press Release
• Positive Sentiment: Raised FY‑2026 revenue guidance — company lifted 2026 revenue guidance to $430M–$445M vs. consensus near $356M, implying materially stronger top‑line growth than analysts expected. Press Release
• Positive Sentiment: Earnings call & investor materials highlight strategy and growth drivers — management commentary and the slide deck underscored durable revenue expansion and product/market traction that support the raised guidance. Earnings Highlights
• Positive Sentiment: Analyst support: Guggenheim reaffirmed a “buy” with a $120 PT — another buy-side vote that can buoy sentiment despite mixed firm-level price target moves. Benzinga
• Positive Sentiment: Positive coverage piece framing BLLN as an attractive investment — broader bullish narratives and coverage can amplify buying interest following the beat and guidance lift. Article
• Neutral Sentiment: Analyst deep‑dive and metric comparisons — outlets (e.g., Zacks) are parsing metrics vs. estimates and prior periods; useful for modeling but not new catalyst. Zacks
• Neutral Sentiment: Q4 snapshot pieces summarize results for retail/institutional readers — helpful context but unlikely to move price independently. LMOnline
• Neutral Sentiment: Short‑interest data appears anomalous/unchanged (reports show zeros/NaN); no clear short squeeze signal from these feeds. (Data quality issue; monitor official FINRA reports.)
• Negative Sentiment: Wells Fargo cut its price target to $90 and set an “equal weight” rating — a downgrade in conviction from that shop could cap near‑term upside and weigh on sentiment for more conservative investors. Benzinga
• Negative Sentiment: BTIG trimmed its target from $160 to $140 (still a “buy”) — target cuts reduce the extent of analyst-driven upside, even if the rating remains positive. Street Insider

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.